凯立新材（688269）：业绩符合预期，产销扩大盈利回暖，基础化工催化剂规模优势显现

Investment Rating - The report maintains an "Outperform" rating for the company [1] Core Insights - The company's performance met expectations, with sales expansion and profit recovery in the basic chemical catalyst sector, highlighting its scale advantages [1] - The company reported a total revenue of 1.687 billion yuan in 2024, a year-on-year decrease of 5.5%, and a net profit attributable to shareholders of 93 million yuan, down 18% year-on-year [6] - In Q1 2025, the company achieved a revenue of 626 million yuan, a year-on-year increase of 105.3%, and a net profit of 22 million yuan, up 90.5% year-on-year [6] Financial Data and Profit Forecast - The company forecasts total revenue of 1.971 billion yuan for 2025, with a year-on-year growth rate of 16.8% [5] - The projected net profit for 2025 is 150 million yuan, reflecting a year-on-year increase of 62.2% [5] - The earnings per share (EPS) is expected to be 1.15 yuan for 2025, with a projected price-to-earnings (PE) ratio of 28 [5] - The gross profit margin is anticipated to improve to 13.6% in 2025, up from 11.2% in 2024 [5] Company Performance and Market Dynamics - The company experienced a significant increase in catalyst sales volume in Q1 2025, with an overall sales increase of 188.87% year-on-year [6] - The pharmaceutical and basic chemical sectors saw sales growth of 174.88% and 285.60% respectively, indicating a strong recovery in demand [6] - The company is leveraging its R&D capabilities to enhance product offerings and expand into new markets, with a notable increase in revenue contribution from the basic chemical sector [6] Future Outlook - The company aims to maintain its profit forecasts for 2025-2026, with net profits projected at 150 million yuan and 215 million yuan respectively [6] - The introduction of new projects and products is expected to support future growth, with a focus on expanding its core competencies in various sectors [6]